^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    volociximab (M200)

    i
    Other names: M200, Eos 200-4, Eos 2004, Eos200-4, M 200, anti-α5β1 integrin antibody, anti-alpha 5 beta 1 integrin antibody
    Associations

    News

    Trials
    Company:
    AbbVie, Biogen
    Drug class:
    α5β1 integrin antagonist
    Associations

    News

    Trials
    10ms
    Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets. (PubMed, Cancer Med)
    This paper underscores the importance of advanced molecular biology and transcriptomics in identifying novel therapeutic targets. The integration of these biomarkers with clinical and radiological assessments using artificial intelligence tools could revolutionize the diagnostics and treatment strategies for patients with bone metastases.
    Review • Journal
    |
    ISLR (Immunoglobulin Superfamily Containing Leucine Rich Repeat) • TNFRSF11B (Tumor necrosis factor receptor superfamily member 11B)
    |
    Cilcane (cilengitide) • abituzumab (EMD 525797) • andecaliximab (GS-5745) • volociximab (M200)